Discover 2,717 paid clinical trials in Ontario. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Filter
1
Filter results
Results: 2,717
Photoacoustic Imaging for Characterizing Breast Masses and Breast Tumor Response to Neoadjuvant Chemotherapy
for
Breast Cancer
Location: Toronto
Sponsor: Sunnybrook Health Sciences Centre
Sex: All
Age: 0+
Code: NCT04428528
Recruiting
Graft Patency in Beating Heart Vs. Conventional CABG Using Cardiac CT
for
Coronary Artery Disease Amenable to Bypass Graft Surgery
Location: Mississauga
Sponsor: Trillium Health Centre
Sex: All
Age: 18+
Code: NCT00259493
Recruiting
Pilot Study of Dose Escalation in Prostate Radiotherapy Using the MR-Linac (DESTINATION-MRL)
for
Prostate Cancer
Location: Toronto
Sponsor: Sunnybrook Health Sciences Centre
Sex: Male
Age: 18+
Code: NCT06177093
Recruiting
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
Location: Hackensack NJ, East Brunswick NJ, Montreal, Ottawa,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT04728893
Phase2, Recruiting
Studying the Effectiveness and Implementation of Sudarshan Kriya Yoga for Canadian Veterans With PTSD
for
PTSD, Depressive Symptoms, Anxiety, Pain, Quality of Life,
Location: Toronto
Sponsor: Mount Sinai Hospital, Canada
Sex: All
Age: 18+
Code: NCT05235828
Recruiting
Abatacept in Immune Checkpoint Inhibitor Myocarditis
for
Myocarditis Acute, Cancer
Location: Portland ME, Boston MA, New York NY, New Brunswick NJ,
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18+
Code: NCT05335928
Phase3, Recruiting
Stroke Canada Optimization of Rehabilitation by Evidence Implementation Trial SCORE-IT)
for
Stroke
Location: Toronto
Sponsor: Toronto Rehabilitation Institute
Sex: All
Age: 18+
Code: NCT00359593
Phase2, Phase3, Recruiting
Use of Quantitative Ultrasound to Guide Adaptive Chemotherapy Among Women With Breast Cancer
for
Breast Cancer
Location: Toronto
Sponsor: Sunnybrook Health Sciences Centre
Sex: Female
Age: 18+
Code: NCT04050228
Recruiting
Study of Neurobehavioral Outcome in Children or Adolescents With Closed Head Injuries
for
Head Injuries, Closed
Location: Toronto, Houston TX, Dallas TX
Sponsor: National Center for Research Resources (NCRR)
Sex: All
Age: 0 - 12
Code: NCT00006128
Recruiting
Health Literacy in Geriatric Patients
for
Health Literacy
Location: Hamilton
Sponsor: Hamilton Health Sciences Corporation
Sex: All
Age: 65 - 70+
Code: NCT06971393
Recruiting
Global Prospective, Observational Cohort of Adult Patients With Primary Sclerosing Cholangitis (WIND-PSC Study)
for
PSC
Location: Boston MA, New Haven CT, Montreal, Richmond VA,
Sponsor: PSC Partners Seeking a Cure
Sex: All
Age: 18 - 70+
Code: NCT06297993
Recruiting
Fetal Ebstein Anomaly and Tricuspid Valve Dysplasia Registry
for
Ebstein Anomaly, Tricuspid Valve Dysplasia
Location: Toronto
Sponsor: The Hospital for Sick Children
Sex: All
Age: 0+
Code: NCT05225311
Recruiting
Osteoporosis Coordinator for Low Volume Community Hospitals
for
Osteoporosis, Fragility Fractures
Location: Toronto
Sponsor: Ontario Ministry of Health and Long Term Care
Sex: All
Age: 40+
Code: NCT00511693
Recruiting
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia
Location: Halifax, Portland ME, Scarborough ME, South Portland ME,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 59
Code: NCT05554393
Phase2, Recruiting
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
for
Recurrent Prostate Cancer
Location: New York NY, Toronto
Sponsor: SpectraCure AB
Sex: Male
Age: 18+
Code: NCT03067051
Phase1, Phase2, Recruiting
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
for
Colorectal Neoplasms
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Sex: All
Age: 18+
Code: NCT05253651
Phase3, Recruiting
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
for
Non-Small Cell Lung Cancer
Location: St. John's, Rimouski, Boston MA, Levis, Stony Brook NY,